BioNexus Gene Lab Corp
Research BioNexus Gene Lab Corp (BGLC) on Bullrun: market cap USD 4.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBGLC
- ExchangeNASDAQ
- CountryMalaysia
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyUSD
- Market capUSD 4.91M
- Financial periodFY2025
- RevenueUSD 7.42M
- Revenue growth-21.9%
- Net income-USD 2.98M
- Free cash flow-USD 1.88M
- Gross margin14.6%
Valuation Snapshot
latest market cap is USD 4.91M.
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
Frequently asked questions
What is BioNexus Gene Lab Corp's market cap?
BioNexus Gene Lab Corp's market capitalization is USD 4.91M.
What does BioNexus Gene Lab Corp do?
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.